Glucocorticoid treatment in community-acquired pneumonia without severe sepsis: No evidence of efficacy

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 9, 2010, Pages 880-882

  Meduri, G Umberto ^a   Bell, W Andrew ^a   Confalonieri, Marco ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; GLUCOCORTICOID; HYDROCORTISONE; PREDNISOLONE;

CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; COMMUNICABLE DISEASE; NOTE; PNEUMONIA;

COMMUNITY-ACQUIRED INFECTIONS; GLUCOCORTICOIDS; HUMANS; PNEUMONIA; TREATMENT OUTCOME;

EID: 77952315141     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201001-0034ED     Document Type: Editorial

References (16)

1. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ. Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 2002;162:1059-1064.
2. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GENIMS) Study. Arch Intern Med 2007;167:1655-1663.
3. Yende S, D'Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, Kong L, Carter M, Angus DC. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008;177:1242-1247. (Pubitemid 351860933)
4. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 2009;136:1631-1643.
5. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005;171:242-248.
6. Snijders D, Daniels JMA, de Graaff CS, van derWerf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia - a randomized double blinded clinical trial. Am J Respir Crit Care Med 181:975-982.
7. Wagner HNJ, Bennett ILJ, Lasagna L, Cluff LE, Rosenthal MB, Mirick GS. The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp 1956;98:197-215.
8. Mikami K, Suzuki M, Kitagawa H, Kawakami M, Hirota N, Yamaguchi H, Narumoto O, Kichikawa Y, Kawai M, Tashimo H, et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 2007;185:249-255.
9. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27-S72.
10. Marik PE, Pastores S, Annane D, Meduri G, Sprung C, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, et al. Clinical practice guidelines for the diagnosis and management of corticosteroid insufficiency in critical illness: recommendations of an international task force. Crit Care Med 2008;36:1937-1949.
11. Nawab Q, Golden E, Confalonieri M, Umberger R, Meduri G. Glucocorticoid treatment in severe community-acquired pneumonia. Am J Respir Crit Care Med 2007;175:A594.
12. Krasner AS. Glucocorticoid-induced adrenal insufficiency [clinical conference]. JAMA 1999;282:671-676.
13. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-871.
14. Meduri GU,Golden E, Freire AX, Taylor E, ZamanM, Carson SJ, Gibson M, Umberger R. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954-963.
15. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009;301:2362-2375.
16. Tang B, Craig J, Eslick G, Seppelt I, McLean A. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009;37:1594-1603.